Quadrant Biosciences

About:

Quadrant Biosciences is an epigenetic diagnostics company focusing on the early detection of neurological disorders.

Website: https://www.quadrantbiosciences.com

Twitter/X: quadbioinc

Top Investors: National Institutes of Health

Description:

Quadrant Biosciences specializes in epigenetic diagnostics with a primary focus on the early identification of neurological disorders and addressing significant healthcare challenges. The company is dedicated to improving lives by delivering innovative diagnostic, therapeutic, and virtual care solutions for global health priorities.

Total Funding Amount:

$9.98M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Syracuse, New York, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)quadrantbiosciences.com

Founders:

Richard Uhlig

Number of Employees:

51-100

Last Funding Date:

2019-12-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai